Efficacy and Safety of MEDI6570 in Patients With a History of Myocardial Infarction
Public ClinicalTrials.gov record NCT04610892. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIB, Randomized, Double Blinded, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of MEDI6570 in Participants With a Prior Myocardial Infarction and Persistent Inflammation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase IIB Parallel group Study to Evaluate the Efficacy and Safety of MEDI6570 in Participants with a Prior Myocardial Infarction.
Study identification
- NCT ID
- NCT04610892
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 423 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 3, 2020
- Primary completion
- Nov 7, 2023
- Completion
- Nov 7, 2023
- Last update posted
- Feb 20, 2025
2020 – 2023
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Mobile | Alabama | 36608 | — |
| Research Site | Beverly Hills | California | 90211 | — |
| Research Site | Covina | California | 91723 | — |
| Research Site | Northridge | California | 91324 | — |
| Research Site | Northridge | California | 91325 | — |
| Research Site | Torrance | California | 90502 | — |
| Research Site | Ponte Vedra | Florida | 32081 | — |
| Research Site | Decatur | Georgia | 30033 | — |
| Research Site | Muncie | Indiana | 47303 | — |
| Research Site | Richmond | Indiana | 47374 | — |
| Research Site | West Des Moines | Iowa | 50266 | — |
| Research Site | Midland | Michigan | 48640 | — |
| Research Site | Columbia | Missouri | 65212 | — |
| Research Site | New Brunswick | New Jersey | 08901 | — |
| Research Site | Buffalo | New York | 14221 | — |
| Research Site | Canton | Ohio | 44710 | — |
| Research Site | Rapid City | South Dakota | 57701 | — |
| Research Site | Winchester | Virginia | 22601 | — |
| Research Site | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04610892, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 20, 2025 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04610892 live on ClinicalTrials.gov.